Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 74.50
+7.20 (10.70%)
At close: Mar 27, 2026
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 14.82 billion as of March 27, 2026.
Market Cap
14.82B
Enterprise Value
14.65B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
74.50
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has increased from 12.97B to 14.82B, an increase of 14.20%. That is a compound annual growth rate of 21.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 13.39B | 31.96% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 16.28B |
| Zai Lab | 15.46B |
| Keymed Biosciences | 14.86B |
| Ascletis Pharma | 14.65B |
| Everest Medicines | 12.46B |
| Guangzhou Innogen Pharmaceutical Group | 10.20B |
| HBM Holdings | 9.78B |
| CStone Pharmaceuticals | 9.72B |